TEM

TEM

USD

Tempus AI Inc. Class A Common Stock

$84.490-0.565 (-0.664%)

即時價格

Healthcare
Health Information Services
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$85.055

最高

$88.880

最低

$83.940

交易量

8.89M

公司基本面

市值

14.7B

行業

Health Information Services

國家

United States

交易統計

平均交易量

9.33M

交易所

NMS

貨幣

USD

52週範圍

最低 $31.36當前 $84.490最高 $104.32

相關新聞

BusinessWire

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim

查看更多
Tempus to Participate in the Stifel 2025 Healthcare Conference
Analyst Upgrades

Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105

Piper Sandler analyst David Westenberg maintains Tempus AI with a Neutral and raises the price target from $70 to $105.

查看更多
Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105
Analyst Upgrades

BTIG Maintains Buy on Tempus AI, Raises Price Target to $96

BTIG analyst Mark Massaro maintains Tempus AI with a Buy and raises the price target from $85 to $96.

查看更多
BTIG Maintains Buy on Tempus AI, Raises Price Target to $96
BusinessWire

Tempus to Report Third Quarter 2025 Financial Results on November 4

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter of 2025 on November 4, 2025. The company will hold the

查看更多
Tempus to Report Third Quarter 2025 Financial Results on November 4
BusinessWire

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the European Society for Medical

查看更多
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
BusinessWire

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency